Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
174 TEM8-driven SynNotch CAR-T cells enable tumor-selective targeting of pancreatic cancer
- 11Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD, USA
- 22Miltenyi Biotec, Clarksburg, MD, USA
- 3Miltenyi Biotec, Gaithersburg, MD, USA
Related
- KRT7CreER Ferrets Enable Lineage Tracing of Ductal Epithelia and Pancreatic Remodeling
- Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer
- Binding kinetics enable tumor-selective MAPK and growth suppression by a Type 1 RAF Inhibitor
- A SynNotch-PiggyBac gene circuit for inflammation-responsive IL-10 delivery in Alzheimer’s disease: a hypothesis and design framework
- Selective AUTAC‐mediated ATP7B degradation unlocks cuproptosis vulnerability in pancreatic ductal adenocarcinoma
BibTeX
@article{dash2026tem8driven,
title = {{174 TEM8-driven SynNotch CAR-T cells enable tumor-selective targeting of pancreatic cancer}},
author = {Pradyot Dash and Bang Vu and Soumyadeep Dey and Nidhi V Dwivedi and Mansi Gulati and Patricia Langan},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0174},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0174},
note = {CC BY},
}
RIS
TY - JOUR
TI - 174 TEM8-driven SynNotch CAR-T cells enable tumor-selective targeting of pancreatic cancer
AU - Pradyot Dash
AU - Bang Vu
AU - Soumyadeep Dey
AU - Nidhi V Dwivedi
AU - Mansi Gulati
AU - Patricia Langan
PY - 2026
DA - 2026/11/05
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0174
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0174
SN - 2051-1426
ER -